Amicus Therapeutics, Inc. (FOLD) Misses Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts FOLD Hot Sheet
Price: $14.49 --0%
Financial Fact:
Total operating expenses: 46.72M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total operating expenses: 46.72M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Amicus Therapeutics, Inc. (NASDAQ: FOLD) reported Q3 EPS of ($0.31), $0.07 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $5.8 million versus the consensus estimate of $8.82 million.
For earnings history and earnings-related data on Amicus Therapeutics, Inc. (FOLD) click here.
For earnings history and earnings-related data on Amicus Therapeutics, Inc. (FOLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Arena Group to rename as Paradium.AI, ticker changing to PAAI
- Ross Stores, Inc. (ROST) PT Raised to $240 at Bernstein SocGen Group
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
